[Anxiety disorders: long-term treatment and replapse prevention]
- PMID: 16502797
[Anxiety disorders: long-term treatment and replapse prevention]
Abstract
Anxiety disorders show a tendency to become chronic. Behavioral treatment and pharmacotherapeutic measures must frequently be applied over a lengthy period of time. The most suitable drugs for long-term treatment are the selective serotonin reuptake inhibitors (SSRI) and the serotonin norepinephrine reuptake inhibitor (SNRI), venlafaxine. With regard to side effects, the specific characteristics of the anti-anxiety drugs used for long-term therapy must be taken into account.
Similar articles
-
[Treatment of anxiety and panic attacks in geriatric psychiatry].Praxis (Bern 1994). 1998 Sep 23;87(39):1252-4. Praxis (Bern 1994). 1998. PMID: 9793416 German.
-
[Pharmacotherapy of panic disorder].Encephale. 1996 Dec;22 Spec No 5:46-53. Encephale. 1996. PMID: 9138947 Review. French.
-
The assessment and treatment of refractory anxiety.J Clin Psychiatry. 1994 Feb;55 Suppl:27-31. J Clin Psychiatry. 1994. PMID: 7915712 Review.
-
Wie lange muss mindestens behandelt werden?MMW Fortschr Med. 2006 Jan;148(4):31-4. doi: 10.1007/BF03364531. MMW Fortschr Med. 2006. PMID: 27387313 German.
-
[Diagnosis and therapy of anxiety disorders].Ther Umsch. 1997 Jul;54(7):380-5. Ther Umsch. 1997. PMID: 9333986 German.
Cited by
-
The role of duloxetine in the treatment of anxiety disorders.Neuropsychiatr Dis Treat. 2008 Oct;4(5):929-35. doi: 10.2147/ndt.s2546. Neuropsychiatr Dis Treat. 2008. PMID: 19183783 Free PMC article.